Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb 5;13(2):e0192097.
doi: 10.1371/journal.pone.0192097. eCollection 2018.

Patient and provider experiences with active surveillance: A scoping review

Claire Kim  1 , Frances C Wright  2 , Nicole J Look Hong  3 , Gary Groot  4 , Lucy Helyer  5 , Pamela Meiers  6 , May Lynn Quan  7 , Robin Urquhart  8 , Rebecca Warburton  9 , Anna R Gagliardi  1
Affiliations

Patient and provider experiences with active surveillance: A scoping review

Claire Kim et al. PLoS One. .

Abstract

Objective: Active surveillance (AS) represents a fundamental shift in managing select cancer patients that initiates treatment only upon disease progression to avoid overtreatment. Given uncertain outcomes, patient engagement could support decision-making about AS. Little is known about how to optimize patient engagement for AS decision-making. This scoping review aimed to characterize research on patient and provider communication about AS, and associated determinants and outcomes.

Methods: MEDLINE, EMBASE, CINAHL, and The Cochrane Library were searched from 2006 to October 2016. English language studies that evaluated cancer patient or provider AS views, experiences or behavioural interventions were eligible. Screening and data extraction were done in duplicate. Summary statistics were used to describe study characteristics and findings.

Results: A total of 2,078 studies were identified, 1,587 were unique, and 1,243 were excluded based on titles/abstracts. Among 344 full-text articles, 73 studies were eligible: 2 ductal carcinoma in situ (DCIS), 4 chronic lymphocytic leukemia (CLL), 6 renal cell carcinoma (RCC) and 61 prostate cancer. The most influential determinant of initiating AS was physician recommendation. Others included higher socioeconomic status, smaller tumor size, comorbid disease, older age, and preference to avoid adverse treatment effects. AS patients desired more information about AS and reassurance about future treatment options, involvement in decision-making and assessment of illness uncertainty and supportive care needs during follow-up. Only three studies of prostate cancer evaluated interventions to improve AS communication or experience.

Conclusions: This study revealed a paucity of research on AS communication for DCIS, RCC and CLL, but generated insight on how to optimize AS discussions in the context of routine care or clinical trials from research on AS for prostate cancer. Further research is needed on AS for patients with DCIS, RCC and CLL, and to evaluate interventions aimed at patients and/or providers to improve AS communication, experience and associated outcomes.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. PRISMA diagrams.
Fig 2
Fig 2. Studies published per year.
See this image and copyright information in PMC

References

    1. Romero-Otero J, García-Gómez B, Duarte-Ojeda JM, Rodríguez-Antolín A, Vilaseca A, Carlsson SV et al. Active surveillance for prostate cancer. Int J Urol 2016;23:211–8. doi: 10.1111/iju.13016 - DOI - PMC - PubMed
    1. Bruinsma S, Roobol M, Carroll P, Klotz L, Pickles T, Moore C et al. Expert consensus document: Semantics in active surveillance for men with localized prostate cancer—results of a modified Delphi consensus procedure. Nat Rev Urol. 2017;14(5):312–322. doi: 10.1038/nrurol.2017.26 - DOI - PubMed
    1. Syed JS, Javier-Desloges J, Tatzel S, Bhagat A, Nguyen KA, Hwang K, et al. Current Management Strategy for Active Surveillance in Prostate Cancer. Curr Oncol Rep 2017;19:11 doi: 10.1007/s11912-017-0569-6 - DOI - PubMed
    1. Timilshina N, Ouellet V, Alibhai SM, Mes-Masson AM, Delvoye N, Drachenberg D et al. Analysis of active surveillance uptake for low-risk localized prostate cancer in Canada: a Canadian multi-institutional study. World J Urol 2017;35:595–603. doi: 10.1007/s00345-016-1897-0 - DOI - PubMed
    1. Volpe A. The role of active surveillance of small renal masses. Int J Surg 2016; 36(Pt C):518–524. doi: 10.1016/j.ijsu.2016.06.007 - DOI - PubMed

Publication types